ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,659.38
0.71%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Leap Therapeutics Inc (LPTX)

  7. Leap Therapeutics Inc (LPTX) Noticias

LPTX Leap Therapeutics Inc

2.11
-0.09 (-4.09%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Leap Therapeutics Inc LPTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.09 -4.09% 2.11 23:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.19 1.985 2.22 2.11 2.20
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
23/5/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
23/5/202415:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/5/202406:10EDGAR2Form 8-K - Current report
13/5/202406:00PRNUSLeap Therapeutics Reports First Quarter 2024 Financial..
13/5/202405:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202416:01EDGAR2Form S-3 - Registration statement under Securities Act of..
11/4/202407:30PRNUSLeap Therapeutics Announces $40 Million Private Placement
18/3/202406:00PRNUSLeap Therapeutics Reports Fourth Quarter and Full Year 2023..
31/1/202420:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202420:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202420:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202420:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202420:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202416:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/1/202416:28EDGAR2Form 8-K - Current report
16/1/202416:10EDGAR2Form 8-K - Current report
16/1/202416:05PRNUSLeap Therapeutics to Present New Clinical Data from Part A..
03/1/202406:00PRNUSLeap Therapeutics to Participate at the 42nd Annual J.P...
02/1/202406:00PRNUSLeap Therapeutics Announces Completion of Enrollment in..
12/12/202315:02EDGAR2Form 8-K - Current report
11/12/202315:05PRNUSLeap Therapeutics to Present New Data from Part A of the..
21/11/202306:00PRNUSLeap Therapeutics to Participate at Piper Sandler 35th..
13/11/202306:10EDGAR2Form 8-K - Current report
13/11/202306:00PRNUSLeap Therapeutics Reports Third Quarter 2023 Financial..
13/11/202305:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/9/202313:44EDGAR2Form 8-K - Current report
05/9/202306:00PRNUSLeap Therapeutics to Participate at Upcoming Investor..
30/8/202315:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
25/8/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202306:10EDGAR2Form 8-K - Current report
14/8/202306:00PRNUSLeap Therapeutics Reports Second Quarter 2023 Financial..
14/8/202305:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/7/202306:10EDGAR2Form 8-K - Current report
12/7/202306:00PRNUSLeap Therapeutics Announces Initiation of Randomized..
20/6/202311:30PRNUSLeap Therapeutics Announces Reverse Stock Split

Su Consulta Reciente

NASDAQ
LPTX
Leap Therapeutics
COIN
BOXUST
Defibox
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados